Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 9, p. 807, doi. 10.2165/11207220-000000000-00000
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2011 AND VI 29 AND IP 9
Results: 6
1
2
Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 9, p. 781, doi. 10.2165/11586560-000000000-00000
- By:
- Publication type:
- Article
3
To Fund or Not to Fund: Development of a Decision-Making Framework for the Coverage of New Health Technologies.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 9, p. 771, doi. 10.2165/11539840-000000000-00000
- By:
- Publication type:
- Article
4
Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure: A Systematic Review.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 9, p. 753, doi. 10.2165/11585990-000000000-00000
- By:
- Publication type:
- Article
5
Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies: Reviewing the Available Evidence.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 9, p. 737, doi. 10.2165/11588370-000000000-00000
- By:
- Publication type:
- Article
6
Value-Based Pricing: Incentive for Innovation or Zero Net Benefit?
- Published in:
- 2011
- By:
- Publication type:
- Editorial